MYOS RENS Technology Stock Price

-0.1208 (-10.23%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
MYOS RENS Technology Inc MYOS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.1208 -10.23% 1.06 17:49:30
Close Price Low Price High Price Open Price Previous Close
1.06 1.065 1.18 1.15 1.1808
Bid Price Ask Price Spread News
1.06 1.13 0.07 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
793 360,600 $ 1.10 $ 398,040 90,830 0.70 - 3.85
Last Trade Time Type Quantity Stock Price Currency
18:48:53 1 $ 1.07 USD

MYOS RENS Technology Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 12.92M 12.19M 6.23M $ 1.03M $ - -0.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 68.00%

more financials information »

MYOS RENS Technology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYOS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.361.3851.0651.27185,066-0.30-22.06%
1 Month1.401.481.0651.33100,501-0.34-24.29%
3 Months1.262.881.0651.811,507,047-0.20-15.87%
6 Months1.023.850.83952.142,757,3770.043.92%
1 Year1.423.850.702.141,419,771-0.36-25.35%
3 Years1.393.850.702.03593,675-0.33-23.74%
5 Years2.717.000.702.42454,883-1.65-60.89%

MYOS RENS Technology Description

Myos Rens Technology Inc is a US-based bio-nutrition and biotherapeutics company. It focuses on the discovery, development, and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. The company develops nutritional and therapeutic products for maintaining and improving the health and performance of muscle tissue. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases such as Sarcopenia, Cachexia, and others.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.